Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Noncontrolling Interests
Balance (in shares) at Dec. 31, 2018		164.0
Balance at beginning of period at Dec. 31, 2018		$ 421	$ (2,765)	$ 1,051	$ 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings				151	1
Other comprehensive income (loss)			41
Issuance of common stock and stock options exercised (in shares)		1.2
Issuance of common stock and stock options exercised		$ 45
Share repurchase program (in shares)		(1.2)
Share repurchase program				(145)
Share-based compensation expenses		$ 27
Issuance of common stock for acquisition (in shares)		1.4
Issuance of common stock for acquisition		$ 160
Dividends declared				(94)
Balance (in shares) at Mar. 30, 2019		165.4
Balance at end of period at Mar. 30, 2019		$ 653	(2,724)	963	18
Balance (in shares) at Dec. 31, 2018		164.0
Balance at beginning of period at Dec. 31, 2018		$ 421	(2,765)	1,051	17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	$ 360
Other comprehensive income (loss)	28
Dividends paid to non-controlling interest on subsidiary common stock	3
Balance (in shares) at Jun. 29, 2019		165.7
Balance at end of period at Jun. 29, 2019		$ 716	(2,737)	1,051	16
Balance (in shares) at Mar. 30, 2019		165.4
Balance at beginning of period at Mar. 30, 2019		$ 653	(2,724)	963	18
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	208			207	1
Other comprehensive income (loss)	(13)		(13)
Issuance of common stock and stock options exercised (in shares)		0.5
Issuance of common stock and stock options exercised		$ 33
Share repurchase program (in shares)		(0.2)
Share repurchase program				(25)
Share-based compensation expenses		$ 30
Dividends declared				(94)
Dividends paid to non-controlling interest on subsidiary common stock					(3)
Balance (in shares) at Jun. 29, 2019		165.7
Balance at end of period at Jun. 29, 2019		$ 716	(2,737)	1,051	16
Balance (in shares) at Dec. 31, 2019		171.0
Balance at beginning of period at Dec. 31, 2019	(683)	$ 501	(2,440)	1,239	17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings				197	1
Other comprehensive income (loss)			(126)
Issuance of common stock and stock options exercised (in shares)		1.3
Issuance of common stock and stock options exercised		$ 5
Share repurchase program (in shares)		(1.6)
Share repurchase program				(253)
Share-based compensation expenses		$ 38
Dividends declared				(109)
Balance (in shares) at Mar. 28, 2020		170.7
Balance at end of period at Mar. 28, 2020		$ 544	(2,566)	1,074	18
Balance (in shares) at Dec. 31, 2019		171.0
Balance at beginning of period at Dec. 31, 2019	(683)	$ 501	(2,440)	1,239	17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	334
Other comprehensive income (loss)	$ (35)
Share repurchase program (in shares)	(2.2)
Dividends paid to non-controlling interest on subsidiary common stock	$ 4
Balance (in shares) at Jun. 27, 2020		170.7
Balance at end of period at Jun. 27, 2020	(815)	$ 628	(2,475)	1,017	15
Balance (in shares) at Mar. 28, 2020		170.7
Balance at beginning of period at Mar. 28, 2020		$ 544	(2,566)	1,074	18
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	136			135	1
Other comprehensive income (loss)	$ 91		91
Issuance of common stock and stock options exercised (in shares)		0.6
Issuance of common stock and stock options exercised		$ 53
Share repurchase program (in shares)	(0.6)	(0.6)
Share repurchase program				(83)
Share-based compensation expenses		$ 31
Dividends declared				(109)
Dividends paid to non-controlling interest on subsidiary common stock					(4)
Balance (in shares) at Jun. 27, 2020		170.7
Balance at end of period at Jun. 27, 2020	$ (815)	$ 628	$ (2,475)	$ 1,017	$ 15